Merck (MRK) News
NYSE: MRKHealth CareBiotechnology: Pharmaceutical PreparationsUSD
145.60+3.22 (+2.26%)
At close: Oct 9, 4:02 PM ET · Delayed 15 min
MRK news summary
We found 37 recent headlines mentioning Merck (MRK): 16 in the past week and 30 in the past 30 days, most often from Nasdaq, Seeking Alpha. For price context, MRK is up 2.26% at $145.60. The most recent story, "Why Moderna Stock Surged Today", was published by Nasdaq on Oct 9, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Merck headlines
- Why Moderna Stock Surged TodayKey PointsThe National Institutes of Health (NIH) is reportedly planning to launch a cancer vaccine development program.NasdaqMRNA, MRK, ET
- 2 Growth Stocks to Buy in OctoberKey PointsGrail’s stock could skyrocket if the FDA approves Galleri.NasdaqMRK, LLY, PFE, VEEV
- HALO Wins Court Order Blocking Merck's Keytruda SC in EuropeHalozyme wins a Dutch court order blocking Merck's Keytruda SC in eight European markets, strengthening its position in the patent dispute.NasdaqHALO, JNJ, MRK, ARGX
- Pfizer's Oncology Outlook: Key Drivers to Watch Ahead of Q3 ResultsPFE's oncology growth in Q3 hinges on key drug sales, biosimilars and progress across a late-stage pipeline.NasdaqPFE, AZN, JNJ, MRK
- INVA vs. MRK: Which Stock Is the Better Value Option?INVA vs. MRK: Which Stock Is the Better Value Option?NasdaqINVA, MRK
- Halozyme Wins Dutch Patent Case Against Merck Over Keytruda SC(RTTNews) - Halozyme Therapeutics, Inc. (HALO) announced that the specialised Dutch patent court of The Hague found that Merck & Co., Inc. (MRK) infringed Halozyme's EP622 patent through its…NasdaqHALO, MRK, ET
- Moderna's Nasdaq-100 Entry: What Does It Mean for the Stock?MRNA's Nasdaq-100 entry follows a 566% stock surge and stronger cancer therapy prospects, potentially boosting demand from index-tracking funds.NasdaqMRNA, MRK, SKYD
- How Is Eli Lilly's Oncology Portfolio Poised Ahead of Q3 Earnings?LLY's oncology portfolio is poised for growth as Jaypirca, Inluriyo and Retevmo may offset slower Verzenio sales and mature-drug declines.NasdaqLLY, AZN, PFE, MRK
- Merck’s injectable Keytruda barred in Europe as Halozyme wins injunctionSeeking Alpha
- New York Declares Statewide Disaster Emergency As Measles Cases Continue To Rise(RTTNews) - Key PointsNasdaq
- Merck (MRK) Beats Stock Market Upswing: What Investors Need to KnowMerck (MRK) reached $141.94 at the closing of the latest trading day, reflecting a +1.72% change compared to its last close.Nasdaq
- Invesco MSCI USA ETF Experiences Big OutflowLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Invesco MSCI USA ETF (Symbol: PBUS) where we have detected an…NasdaqPBUS, MRK, KO, MS
- Merck Stock Down 7% in a Month: Is the Dip a Buying Opportunity?Merck's 7% dip may offer a buying opportunity as Keytruda drives growth and new products and pipeline assets strengthen its post-2028 outlook.NasdaqMRK, AZN, MRNA
- Dow Movers: MRK, HONIVIn early trading on Monday, shares of Honeywell International topped the list of the day's best performing Dow Jones Industrial Average components, trading up 7.5%. Year to date, Honeywell…NasdaqMRK, NKE, MSFT
- PGEN Stock Up More Than 50% in 3 Months: Here's What You Should KnowPrecigen is building momentum with Papzimeos sales growth, a European regulatory review and progress across its AdenoVerse pipeline.NasdaqPGEN, MRK, INO
- 3 Income Stocks Under $30 That Yield More Than the 10-Year Treasury NoteThe 10-year Treasury note yielded around 5.3% in late September. One month before, it was around 4.78%, and it's up by more than a full percentage point from where it was one year ago. To put that…NasdaqPFE, LLY, ABBV, MRK
- 3 of the Best ETFs to Buy and Hold if a Recession Is ComingKey PointsVHT is a diversified play on the non-cyclical healthcare sector.NasdaqMRK, MSFT, GOOGL, AAPL
- Merck's Tulisokibart Meets Endpoints in Hidradenitis Suppurativa StudyMRK's tulisokibart meets the phase IIb HS study's primary endpoint, with high and medium-dose regimens showing superiority over placebo at week 16.NasdaqMRK, AMRN, ACIU, ARQT
- ABBV Stock Rises 25% in 6 Months: Time to Buy, Hold or Sell?AbbVie's stock climbs 25.4% in six months as Skyrizi, Rinvoq and neuroscience drugs fuel growth, but Humira erosion and competitive pressures remain.NasdaqABBV, JNJ, MRK, LLY
- Why Merck (MRK) Dipped More Than Broader Market TodayIn the latest trading session, Merck (MRK) closed at $145.31, marking a -2.66% move from the previous day.Nasdaq
- Top Analyst Reports for Apple, Microsoft & BroadcomApple, Microsoft and Broadcom face contrasting growth drivers and risks, from AI and cloud demand to capacity constraints and customer concentration.NasdaqAAPL, MSFT, AVGO, CCL
- Prediction: Moderna Stock Will Soar 100% by 2030Key PointsModerna was known for its coronavirus vaccine a few years ago, but it’s greatly expanded its pipeline in recent years.NasdaqMRNA, MRK
- Moderna vs. BioNTech: Which mRNA Stock Is the Better Buy Now?MRNA's respiratory vaccine expansion and promising oncology results offer potential growth as COVID-19 demand normalizes.NasdaqMRNA, BNTX, PFE, MRK
- Merck, Daiichi Withdraw FDA Filing for Lung Cancer TherapyMRK and Daiichi withdraw an FDA filing for ifinatamab deruxtecan after data falls short, while late-stage studies continue.NasdaqMRK, GSK
- Merck's Melt-Up Triggers Profit-Taking Risks - Multi-Year Portfolio Renewal (Rating Downgrade)Seeking Alpha
- MRNA Hits 52-Week High: How Melanoma Study Results Keep Rally GoingModerna's 52-week high follows positive melanoma results, with detailed phase III data set for an ESMO presentation.NasdaqMRNA, SNY, PFE, MRK
- BioNTech Stock Recently Got Downgraded. But Is Wall Street Underestimating Its Cancer Pipeline?Key PointsBMO Capital Markets downgraded BioNTech and lowered its price target for the stock.NasdaqBNTX, MRK, BMO, MRNA
- Merck: Time To Trim, Overvalued, And Overbought (Rating Downgrade)Seeking Alpha
- Merck & Co., Inc. (MRK) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking AlphaMRK, MS
- These 5 ETFs Are Built for Bear Markets. History Says Now Is a Fantastic Time to Buy.Key PointsTo brace against market pullbacks, add some defensive stocks or funds to your mix.NasdaqVHT, VZ, WMT, MRK
- The Zacks Analyst Blog Highlights Oracle, Merck, Union Pacific, CVD Equipment and Koil Energy SolutionsOracle, Merck and Union Pacific headline fresh research, while microcaps CVD Equipment and Koil Energy show strong gains with distinct growth drivers.NasdaqMRK, UNP, ORCL, CVV
- Top Stock Reports for Oracle, Merck & Union PacificOracle, Merck and Union Pacific lead today's stock reports, with cloud growth, drug sales and rail strength driving their investment stories.NasdaqMRK, UNP, ORCL, CVV
- Revolution Medicines Got Its Breakthrough—What Moves It Next?Revolution Medicines (NASDAQ: RVMD) just landed one of the biggest wins in oncology this year, and the stock barely blinked. On Aug. 26, the FDA approved RASONQUE (daraxonrasib), the first broad…NasdaqRVMD, LLY, AMGN, MRK
- Stocks Settle Higher as Crude Oil Prices StabilizeThe S&P 500 Index ($SPX ) (SPY ) closed up by +0.43% on Friday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up by +0.98%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up by +0.33%.…NasdaqMSTR, TER, AMAT, B
- Weekly Buzz: RARE, REGN Secure FDA Nod, BMRN Stikes Deal; HUMA, EYPT Face Trial Setbacks(RTTNews) - This week's global biopharma roundup captured a mix of regulatory approvals, strategic partnerships, acquisitions, and merger activity, alongside clinical trial breakthroughs and halts.…NasdaqALIT, ARGX, AZN, BMRN
- Stocks Mixed on Lower Bond Yields and Chip Stock WeaknessThe S&P 500 Index ($SPX ) (SPY ) is up by +0.33% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up by +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.33%. E-mini S&P…NasdaqAMAT, B, AVGO, HL
- Pre-Market Most Active for Aug 19, 2026 : CAST, MRNA, SKDD, SKHY, SKUU, MUU, NOK, MRK, STLA, LYG, NIO, PFEThe NASDAQ 100 Pre-Market Indicator is up 99.74 to 29,590.7. The total Pre-Market volume is currently 146,830,338 shares traded.The following are the most active stocks for the pre-market session:…NasdaqCAST, MRNA, MUU, NOK